Catalyst News and Research

RSS

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

3 Dec 2009

Medical research experts explore new strategies to speed up treatments for medical disorders

Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.

3 Dec 2009

Veeco Instruments introduces ScanAsyst and PeakForce QNM scan modes

Veeco Instruments Inc., the leading provider of atomic force microscope (AFM) instrumentation to the Research and Industrial communities, announced today the introduction of two patent-pending AFM scan modes, ScanAsyst™ and PeakForce™ QNM™.

2 Dec 2009

Novel initiative to improve NMR structure determination

In structural biology, the only technique available to predict the three dimensional structure of large complex molecules in solution, such as proteins and DNA, is NMR spectroscopy. To catalyze improvements in the techniques behind these predictions, the "eNMR" project has launched a new initiative. In September's Nature Methods the project issued an invitation to the entire biomolecular Nuclear Magnetic Resonance community to participate in a large scale test of modern computing algorithms.

30 Nov 2009

JDRF partners with the Canadian Government in diabetes research

Juvenile Diabetes Research Foundation (JDRF) Canada is pleased to announce its first partnership with the Government of Canada through the Federal Economic Development Agency of Southern Ontario. Through this innovative two-year partnership, the Government of Canada is committing $20 million and JDRF is making a matching contribution of $10 million to accelerate world-class diabetes research in Southern Ontario by implementing a clinical trial network for diabetes research.

23 Nov 2009

Nightingale Informatix announces financial results for the quarter and six months ended September 30, 2009

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and six months ended September 30, 2009. All results are reported in Canadian dollars unless otherwise stated.

23 Nov 2009

Fred Hutchinson Cancer Research Center receives $10 million to advance biomedical research

Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.

23 Nov 2009

Inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair chosen

Renowned B.C. kinesiologist and heart disease researcher Dr. Scott Lear is the inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Disease Prevention Research at St. Paul's Hospital, established in partnership with Simon Fraser University (SFU).

21 Nov 2009

UNGASS monitoring system provides the overall progress in the global response to HIV

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic. An update on the development of the UN General Assembly Special Session on HIV/AIDS (UNGASS) global reporting system appears in a special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes.

19 Nov 2009

New biomarkers can predict patients' response to certain drugs

Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.

19 Nov 2009

Fully integrated human genome sequencing and data processing service launched

Knome, Inc., a recognized pioneer in the personal genomics field, today announced the launch of KnomeDISCOVERY, the first fully integrated human genome sequencing and data processing service for researchers. The new offering meets rapidly emerging demand from biomedical researchers for a one-stop service that bundles affordable, research-tailored access to a broad range of next-generation sequencing platforms with discovery-supportive data management and analysis.

18 Nov 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. Clifton Mining Company is a major shareholder in American Biotech Labs.

17 Nov 2009

Sentillion reaches milestone: More than 500,000 “live” caregivers use their solutions daily

Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced that over 500,000 users are live and productively using its single sign-on and context management solutions. Leading healthcare organizations, ranging from single facilities to large, complex, multi-state health systems are part of a 160+ customer community that has deployed Sentillion’s IAM solutions enterprise-wide in over 1,000 hospitals.

16 Nov 2009

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex.

16 Nov 2009

Tianyin Pharmaceutical reports 40.2% increase in revenues for the first quarter of fiscal 2010

Tianyin Pharmaceutical Co., Inc., a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced fiscal results for its first quarter ended September 30, 2009.

13 Nov 2009

Regence BlueCross recognized as Platinum-Level Start! Fit-Friendly Company

Regence BlueCross BlueShield has been recognized as a Platinum-Level Start! Fit-Friendly Company by the American Heart Association's Start! movement for helping employees eat better and move more.

13 Nov 2009

DFG to strengthen its support for young researchers, approves establishment of 11 new Research Training Groups

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has intensified its efforts to strengthen its support of young researchers. At its fall session in Bonn, the responsible Grants Committee of Germany's central research funding organisation approved the establishment of eleven new Research Training Groups. In these groups, doctoral researchers can earn their doctorates in a structured research and qualification programme.

13 Nov 2009

Third-quarter 2009 results announced by Catalyst Pharmaceutical

Catalyst Pharmaceutical Partners, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

Co-founders of Signature Genomics recognized with Inland Northwest Catalyst Award

Signature Genomics, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, today announced company co-founders Dr. Lisa G. Shaffer, Ph.D., and Dr. Bassem A. Bejjani, M.D. have received the 2009 Inland Northwest Catalyst Award for Innovators of the Year.

12 Nov 2009

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Catalyst Pharmaceutical Partners, Inc. today reported that a team of neuroscientists at The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System (LIJ) has received a $1.2 million grant from the U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate addiction.

10 Nov 2009

Catalyst News and Research

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

Medical research experts explore new strategies to speed up treatments for medical disorders

Veeco Instruments introduces ScanAsyst and PeakForce QNM scan modes

Novel initiative to improve NMR structure determination

JDRF partners with the Canadian Government in diabetes research

Nightingale Informatix announces financial results for the quarter and six months ended September 30, 2009

Fred Hutchinson Cancer Research Center receives $10 million to advance biomedical research

Inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair chosen

UNGASS monitoring system provides the overall progress in the global response to HIV

New biomarkers can predict patients' response to certain drugs

Fully integrated human genome sequencing and data processing service launched

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

Sentillion reaches milestone: More than 500,000 “live” caregivers use their solutions daily

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Tianyin Pharmaceutical reports 40.2% increase in revenues for the first quarter of fiscal 2010

Regence BlueCross recognized as Platinum-Level Start! Fit-Friendly Company

DFG to strengthen its support for young researchers, approves establishment of 11 new Research Training Groups

Third-quarter 2009 results announced by Catalyst Pharmaceutical

Co-founders of Signature Genomics recognized with Inland Northwest Catalyst Award

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News